Showing results (1251-1260 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|May 21, 2016
Are there, or shall we discover, biomarkers to guide PD-1 inhibition?Paolo A Ascierto, Ramon Andrade de MelloImmunotherapy|May 11, 2016
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedsideChantal Kuhn, Howard L WeinerImmunotherapy|May 4, 2016
Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse modelBhawna PooniaImmunotherapy|May 4, 2016
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promisesCristina Bagacean, Mihnea Zdrenghea, Adrian Tempescul, et al.Immunotherapy|October 8, 2014
Role of subcutaneous formulation of trastuzumab in the treatment of patients with HER2-positive breast cancerBohuslav Melichar, Hana Študentová, Hana Kalábová, et al.Immunotherapy|June 29, 2016
Immune checkpoint inhibitors side effects and managementHampig Raphael Kourie, Jean KlasterskyImmunotherapy|June 29, 2016
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignanciesMurali Janakiram, Vipul Pareek, Haiying Cheng, et al.Immunotherapy|June 29, 2016
Immune checkpoint inhibitor combinations in solid tumors: opportunities and challengesChrisann Kyi, Michael A PostowImmunotherapy|July 7, 2016
Antibody-targeted nanoparticles for cancer treatmentThomas Carter, Paul Mulholland, Kerry ChesterImmunotherapy|December 20, 2014
Current advances in T-cell-based cancer immunotherapyMingjun Wang, Bingnan Yin, Helen Y Wang, et al.Pageof 188